INSIGHTS ON CONTRACT PHARMA MANUFACTURING
-
Supporting A Company In Manufacturing The RSM For Treating A Rare Tumour
A clinical-stage oncology company needed a partner to manufacture the RSM. Examine how an optimized RSM manufacturing process helped deliver safe, effective treatment on an accelerated timeline.
-
The Growth Of Sterile Injectables
Partnering with a manufacturer capable of delivering flexible aseptic fill-finish solutions for both small and large-scale production runs is essential for delivering products to patients safely and efficiently.
-
Detection And Quantification Of Process-Related Impurities
Finding a partner with the expertise and capabilities to provide solutions for detecting and quantifying process-related impurities ensures the successful development and manufacturing of safe and effective products.
-
High Potent Formulation Development In Oncology
Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.
-
Pharma Research, Development, And Launches Saves Lives — And The Earth
Discover how a defined framework and way of measuring allows companies to align priorities, short- or long-term goals, and what ESG success looks like in terms of tangible measurements.
-
CDMO Management for Sponsors — Part 2: Handling SOPs, Multiple Partnerships, and M&A Disruptions
Day-to-day discussions between technical teams and regular brainstorming/exchange-of-information meetings are commonly understood to be vital to a partnership — ensuring the sponsor and vendor understand each other’s long- and short-term priorities — but problem-solving and mediation are equally critical communication skills.
-
CDMO Management for Sponsors — Part 1: Identify Partners and Nail Project Kickoff
Identifying an appropriate CDMO partner and establishing relationship structure/expectations early is an intrinsic part of leveraging the CDMO to provide the sponsor a competitive advantage. A good partner blurs the line between third-party service and extension of your company.
-
Streamlining Viral Vector Development And Manufacturing For Gene Therapies
Learn about MilliporeSigma's capabilities and solutions for gene therapy production as experts highlight key features of their technologies and infrastructure through a virtual tour of the GMP manufacturing facility.
-
Get To The GMP Clinical Stage Quickly Utilizing Scale Down Models
Explore how scale-down models can shorten timelines, accelerate process development, and advance your novel therapy to the GMP clinical stage with speed and reduced costs.
-
Conduits Of Industry Intel
Martin Lehr, CEO, Context Therapeutics, explains a key role of consultants – one that should be utilized more – is that of information and intelligence sources for what is happening throughout our industry.